Frost & Sullivan China’s Specialized Research Platform
Smart Nutraceuticals for Brain Health
2026
MedTech
Every leadership team has a strategy. Most have identified the right growth opportunities. Many have invested heavily in technology, AI, innovation, and transformation. Yet nearly 70% of strategic transformations fail to create lasting business value.
Why?
Because the real challenge is no longer strategy, it is implementation.
Click here to check out the leadership perspective from David Frigstad, Chairman & CEO, Frost & Sullivan.
Click here to access our whitepaper titled "The Connected CEO: Leading Through the Intelligence Revolution".
You can also explore our latest whitepaper titled "The Connected CEO: 10 Strategic Imperatives for the Intelligence Revolution" and join our exclusive webinar "Connected CEO: Top 10 Innovative Perspectives on the Intelligence Revolution" to learn more.
- Adopt payer landscape intelligence to deliver differentiated value.
- Which leading organizations are benchmarked in this analysis?
- Utilize the increasing demand for data-driven decision-making.
- Incorporate AI and laboratory automation to improve productivity.
- How are molecular complexity and patent expiries driving growth?
- Align with sustainability to strengthen your competitive edge.
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Matt Goche
From Digital Signage to Mission-critical Digital Engagement: How Uniguest Is Scaling Intelligent Customer Experiences
Matt Goche
CEO | Uniguest
Interview with Dr. Adriana Kiędzierska-Mencfeld
From Biosimilars to a Flexible CDMO Model: Rezon Bio’s Strategy for Growth
Dr. Adriana Kiędzierska-Mencfeld
CEO | Rezon Bio
Interview with Elizabeth Koff
The Evolution from Enterprise Data Interoperability to Real-time Intelligence: Unlocking the Full Potential of Connected Care
Elizabeth Koff
Managing Director | Telstra Health
Interview with Farhoud Salimi
The Evolution from Enterprise Data Interoperability to Real-time Intelligence: Unlocking the Full Potential of Connected Care
Farhoud Salimi
Chief Technology Officer | Telstra Health
Interview with Ranjit Singh
Reimagining Healthcare Financing in Malaysia: Bridging the Gap Between Need and Affordability
Ranjit Singh
Founder & CEO | Amden Capital Sdn Bhd
Interview with Dr. Sven Abend
Building on Lactose Leadership: DFE Pharma’s Evolution into an Excipient Innovation Platform
Dr. Sven Abend
CEO | DFE Pharma
Navigating Transformation – Middle East (September 2026 Edition)
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Examine growth prospects across medical imagery, neuromodulation devices, and capnography devices industries.

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Capture growth across landscapes like the United States (US) population health management and healthcare cloud.
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Frost & Sullivan welcomed more than 2,000 business leaders, policymakers, investors, academics and innovators to the 20th Growth, Innovation and Leadership (GIL) Summit in China, held August 4–5 at the Jing An Shangri-La in Shanghai.
Coinciding with Frost & Sullivan’s 65th anniversary, the summit featured more than 300 speakers and 150 keynote presentations and panel discussions. Topics included artificial intelligence, advanced manufacturing, semiconductors, life sciences, consumer markets and investment - highlighting the forces reshaping global competitiveness and transformational growth.
The event combined a flagship plenary programme with 10 parallel forums and the fifth edition of Frost & Sullivan’s New Investment Event, fostering collaboration across business, finance, government, academia and research.
.jpg)
Frost & Sullivan is strengthening its China market intelligence capabilities through the Frost & Sullivan China LeadLeo platform, offering one of the most comprehensive and differentiated research resources dedicated to China’s industrial and business landscape.
China’s remarkable advances across artificial intelligence, electric mobility, advanced manufacturing, biotechnology, renewable energy, high-speed rail and numerous other sectors have cemented its position as a global powerhouse of technological innovation.
Frost & Sullivan subscription customers can now access specialised China-market intelligence alongside the company’s extensive global market coverage, gaining a more complete view of the transformation of China’s industries, resulting growth opportunities, market intelligence, trends, and action-oriented data.
Home Care Digitalization: Growth Opportunities in Intelligent, Data-driven Care
Home care is becoming a larger part of healthcare delivery as more people manage long-term health needs from home. This shift is creating a stronger need for digital tools that help providers deliver care more consistently, whether through virtual visits, remote patient monitoring platforms, or smart medication management.
Global Medical Imaging Industry: How AI, Theranostics, and Connected Imaging Are Changing Care Delivery
Rising diagnostic volumes, chronic disease prevalence, and pressure for faster clinical decisions are changing the global medical imaging equipment and informatics industry. Image quality and system performance remain important, but healthcare providers also need solutions that can ease workloads and shorten the path from scanning to clinical action.
Behavioral Health Management: How Digital Health Solutions Are Moving Care Beyond Treatment
Demand for mental health services continues to rise, but traditional care models are struggling to keep pace. Persistent workforce shortages and limited access to timely support are prompting employers, payers, and health systems to reconsider how behavioral healthcare is delivered. Reflecting this change, the global digital health solutions industry for behavioral health management is projected to reach $9,956.0 million by 2031, at a CAGR of 14.9%.
Molecular Diagnostics Industry: How AI, NGS, and Liquid Biopsy Are Shaping Growth
The molecular diagnostics industry is consolidating as companies acquire proprietary testing platforms to expand in precision oncology and blood-based diagnostics. These transactions provide the experimental, commercial, and financial capacity needed to move new tests into routine care. At the same time, digital polymerase chain reaction (dPCR), next-generation sequencing (NGS), CRISPR-associated systems (CRISPR-Cas), and nanotechnology are being combined to improve testing speed, accuracy, and scale.
DrFirst Receives Frost & Sullivan’s 2026 North America Enabling Technology Leadership Recognition for Advancing AI-enhanced Medication Orchestration
As healthcare organizations continue to navigate fragmented medication workflows, rising administrative complexity, and growing demands for faster patient access, DrFirst is transforming how prescriptions move from creation to fulfillment. The company is honored for its AI-enhanced medication orchestration platform with Frost & Sullivan’s 2026 North America Enabling Technology Leadership Recognition in Intelligent Medication Management, citing a new model of prescribing architecture that unites clinical insight, operational efficiency, and patient-centered care.
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- Becton Dickinson pledges $19 billion US investment in deal with government
- US government, Google join Zuckerberg-backed Biohub in $1.8 billion push for AI biology data
- Abbott cuts 2026 sales growth view, plans to spin off nutrition business
- Novo to pay up to $2.6 billion to China's Hengrui for rights to weight-loss pill
- GSK to nearly double cancer medicines in clinical trials next year
Frost & Sullivan Institute
Click Here to explore our latest blog on "Bioprocessing 4.0".
CUSTOMER ENGAGEMENT NEWSLETTER
Strategies and Tactics for Extraordinary Times
Subscribe Now to the monthly newsletter to explore major articles, insights, spotlight videos, upcoming events, council info and more.
THE INNOVATION NEWSLETTER
Inspiration and Best Practices to Help You Maximize Growth
Subscribe Now to the quarterly newsletter to access new articles, insights, spotlight blogs, upcoming events, council info and more.
Capture growth opportunities across conversational AI in patient engagement, healthcare infrastructure cybersecurity, and real-time location systems (RTLS).
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
Bio Middle East
Dates: 14th to 16th December 2026
Venue: Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
BIO Middle East is the region’s dedicated biotechnology event, bringing together biotech innovators, pharmaceutical leaders, investors, researchers and policymakers. Taking place in Riyadh, Saudi Arabia, the event focuses on advancing biotechnology, biomanufacturing, precision medicine, investment and R&D partnerships, creating opportunities for collaboration and business growth across the Middle East and beyond.
The 20th Frost & Sullivan Global Growth, Innovation, and Leadership Summit and the 5th New Investment Event
Dates: 4-5 August 2026
Venue: Shanghai, China
On August 4-5, 2026, the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Event will have its grand opening at the Shangri La Hotel in Jing'an, Shanghai. This will also mark the 20th year milestone for Frost & Sullivan China to continue building on an international high-end communication platform for enterprises across China as well as the rest of the world.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.

